Outgoings expected to be around 5.8m next quarter, so I'd still expect incomings to be higher (considering costs should be down).. That means another profitable quarter ahead, despite any December slowdown.. The 2 quarters following that should be really good with Pegasus at full scale & new product lines coming online (with active sales), plus the possibility of finally getting a licensee for Alexiflam NF..
Ann: Appendix 4C - quarterly, page-21
-
- There are more pages in this discussion • 229 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AJX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
1.2¢ |
Change
0.000(0.00%) |
Mkt cap ! $18.74M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 334317 | 1.1¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 1.2¢ | 100000 | 1 |
View Market Depth
| Last trade - 16.12pm 05/07/2024 (20 minute delay) ? |
| AJX (ASX) Chart |
Day chart unavailable